Member Exclusive Drug approvals

New drug approvals: July 2018

July has seen a plethora of new drug approvals, including the US FDA's approval of iobenguane I 131, the first and only treatment for a rare adrenal cancer. Find out more in this round-up of the new therapies on the market.

Go to the profile of RxNet
Aug 01, 2018

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.